Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aucubin is a naturally occurring iridoid glycoside found in various medicinal plants, most notably in the bark of *Eucommia ulmoides* (Eucommiae Cortex) and *Plantago* species. It functions as a phytoestrogen with selective activity toward the **estrogen receptor beta (ERβ)**. In preclinical models of musculoskeletal disorders, particularly **tendinopathy**, aucubin has demonstrated significant therapeutic potential by promoting tenocyte migration, enhancing the synthesis of mature Type I collagen, and increasing collagen fibril diameter. Its mechanism of action involves a multifaceted approach: it mitigates oxidative stress by scavenging reactive oxygen species (ROS) and increasing superoxide dismutase (SOD) activity, suppresses pro-inflammatory cytokines such as IL-1β and TNF-α, and inhibits apoptosis by downregulating cleaved caspase-3. Furthermore, it helps maintain extracellular matrix homeostasis by inhibiting matrix-degrading enzymes like MMP-3 and MMP-13, thereby facilitating regenerative tissue repair rather than scar formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aucubin.